Literature DB >> 3060290

Hemangiopericytoma of the meninges: a clinicopathologic and immunohistochemical study.

T Iwaki1, M Fukui, I Takeshita, M Tsuneyoshi, J Tateishi.   

Abstract

This clinicopathologic study concerns 15 cases of hemangiopericytoma of the meninges (so-called hemangiopericytic meningioma) among approximately 300 examined cases. Ages of the patients at the first surgery ranged from 25 to 67 years, with a median of 44 years. According to follow-up information, 9 of the 15 died between 1 year and 15 years after the initial treatment. Histologically, the tumor was indistinguishable from the hemangiopericytomas in other tissues and was characterized by a homogeneous vascular pattern, a uniform cell population and a wide range of cellular anaplasia. The presence of prominent mitotic activity suggested a highly active biological behavior. Immunohistochemical analyses for epithelial membrane antigen (EMA) were done in 35 various meningiomas, 12 meningeal hemangiopericytomas, and three extracranial hemangiopericytomas. Most of the meningiomas of meningotheliomatous, transitional, fibroblastic, papillary, angiomatous, and anaplastic types showed a positive immunoreactivity for EMA, while all of the meningeal hemangiopericytomas and extracranial hemangiopericytomas examined were negative for EMA. Our immunohistochemical study may support the concept that the meningeal hemangiopericytoma is composed of poorly differentiated cells which may originate from a perivascular mesenchymal cell of the meninges but not from the arachnoidal cap cell.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060290

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  11 in total

1.  Management of intracranial meningeal hemangiopericytomas: outcome and experience.

Authors:  K N Fountas; E Kapsalaki; M Kassam; C H Feltes; V G Dimopoulos; J S Robinson; J R Smith
Journal:  Neurosurg Rev       Date:  2006-01-04       Impact factor: 3.042

2.  Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions.

Authors:  T Iwaki; T Wisniewski; A Iwaki; E Corbin; N Tomokane; J Tateishi; J E Goldman
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

3.  Histogenesis of intracranial haemangiopericytoma and haemangioblastoma. An immunohistochemical study.

Authors:  P H Theunissen; M Debets-Te Baerts; G Blaauw
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Immunohistochemical and genetic markers to distinguish hemangiopericytoma and meningioma.

Authors:  Penglai Zhao; Tongming Zhu; Qisheng Tang; Hongyi Liu; Jianhong Zhu; Wenbin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

5.  Hemangiopericytoma: collision with meningioma and recurrence.

Authors:  Emanuela Binello; Joshua B Bederson; George M Kleinman
Journal:  Neurol Sci       Date:  2010-03-03       Impact factor: 3.307

6.  Metastasis in meningioma.

Authors:  S A Enam; S Abdulrauf; B Mehta; G M Malik; A Mahmood
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

7.  Rare hypervascular pancreatic tumors diagnosed as asynchronous metastases of central nervous system solitary fibrous tumor/hemangiopericytoma.

Authors:  Kenta Mizukoshi; Yuki Yamauchi; Mami Kitaura; Akihisa Fukuda; Hiroshi Seno
Journal:  Clin J Gastroenterol       Date:  2021-10-15

8.  Giant supratentorial meningeal haemangiopericytoma in a newborn.

Authors:  N Aouad; C Vital; J Rivel; K Ramsoubramanian; S Santosh; O Chowdry
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 9.  Pancreatic metastases of cerebellar hemangiopericytoma occurring 24 years after initial presentation: report of a case.

Authors:  Takanori Hiraide; Takanori Sakaguchi; Yasushi Shibasaki; Yoshifumi Morita; Atsushi Suzuki; Keisuke Inaba; Tsutomu Tokuyama; Satoshi Baba; Shohachi Suzuki; Hiroyuki Konno
Journal:  Surg Today       Date:  2012-11-21       Impact factor: 2.549

10.  Hemangiopericytomas of the spine: case report and review of the literature.

Authors:  Chad D Cole; Meic H Schmidt
Journal:  Rare Tumors       Date:  2009-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.